SCCM is performing maintenance on its websites. For the best browsing experience, please use Microsoft Edge or Safari. Those using Chrome or Firefox may experience access issues at this time.

Tag: respiratory

Tag Search

visual bubble
visual bubble
visual bubble
visual bubble

SCCM Africa Infrastructure Relief and Support Project Will Improve Access to Oxygen in West Africa

The Society of Critical Care Medicine’s (SCCM) new global health initiative, Africa Infrastructure Relief and Support (AIRS), will ensure the availability of medical oxygen to patients in the Gambia, Liberia, and Sierra Leone, made possible by a $5.5 million grant from Direct Relief and in collaboration with the Johns Hopkins Global Alliance of Perioperative Professionals (GAPP) and the Institute of Global Perioperative Care. Officials in the Gambia, Liberia, and Sierra Leone will identify specific medical oxygen-related needs, including hospital-based infrastructure, oxygen-generating plants, and solar energy. SCCM plans to eventually expand the initiative to additional countries.


SCCM Pod-379 Opioid-Induced Respiratory Depression Risk Prediction Tool

Ludwig H. Lin, MD, and Ashish K. Khanna, MD, FCCP, FCCM, discuss Dr. Khanna’s top-rated abstract, Derivation and Validation of a Novel Opioid-Induced Respiratory Depression Risk Prediction Tool (Khanna A, et al. Crit Care Med. 2019;47:18), from the Society of Critical Care Medicine’s 48th Critical Care Congress.


SCCM Pod-424 Critical Care Implications of Respiratory Depression on Hospital Wards

Continuous monitoring on hospital wards can prevent adverse events and unnecessary ICU admissions. Michael Smith, MD, is joined by Ashish K. Khanna, MD, FCCP, FCCM, to review the demographics of respiratory depression.


Concise Critical Appraisal: Awake Prone Positioning For COVID-19 Acute Hypoxemic Respiratory Failure

This Concise Critical Appraisal explores an article in The Lancet Respiratory Medicine that evaluated the efficacy of awake prone positioning to prevent intubation or death in patients with severe COVID-19. This meta-trial used a new study design that allowed for the combination of six simultaneous national randomized, controlled, open-label trials.